Rodino-Klapac Louise

Rodino-Klapac Louise is listed in filings as President at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 13, 2026, including 27 public disclosures. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT). The current snapshot covers public activity from Jun 25, 2024 to Mar 13, 2026. Reported amounts are shown as $16.1K to $8.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.